# Antiproteinuric Agents and Fabry Disease

> **NCT00343577** · — · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 12 (—)

## Conditions studied

- Fabry Disease
- Proteinuria

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00343577
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 12 (—)
- **Last updated:** 2013-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00343577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00343577, "Antiproteinuric Agents and Fabry Disease". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00343577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*